NCT05283850View on ClinicalTrials.gov

Surviving PEA in Roanoke (SPEAR) Study

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

342

Participants

Timeline

Start Date

February 16, 2022

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions
Cardiac ArrestPulseless Electrical Activity
Interventions
DRUG

High Calcium, Low Sodium (HCLS) Crystalloid Therapy

Half-normal saline IV drip and 1g IV bolus Calcium Chloride.

DRUG

High Calcium, High Sodium (HCHS) Crystalloid Therapy

Normal saline IV drip and 1g IV bolus Calcium Chloride.

Trial Locations (1)

24014

RECRUITING

Carilion Clinic, Roanoke

All Listed Sponsors
collaborator

Virginia Polytechnic Institute and State University

OTHER

lead

Carol Bernier

OTHER